Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Work In Process (2019 - 2025)

Outset Medical (OM) has disclosed Work In Process for 7 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Work In Process fell 26.64% to $7.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 million, a 26.64% decrease, with the full-year FY2025 number at $7.3 million, down 26.64% from a year prior.
  • Work In Process was $7.3 million for Q4 2025 at Outset Medical, down from $7.5 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $13.9 million in Q3 2024 to a low of $6.1 million in Q4 2021.
  • A 5-year average of $9.4 million and a median of $9.3 million in 2022 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: skyrocketed 163.81% in 2021, then tumbled 46.24% in 2025.
  • Outset Medical's Work In Process stood at $6.1 million in 2021, then surged by 50.08% to $9.1 million in 2022, then fell by 3.94% to $8.7 million in 2023, then rose by 14.26% to $10.0 million in 2024, then decreased by 26.64% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Work In Process are $7.3 million (Q4 2025), $7.5 million (Q3 2025), and $7.6 million (Q2 2025).